More direct evidence supporting our hypothesis was shown in ovarian cancer-derived cell lines where silencing of GBA with siRNA led to significantly decreased activation of the Axl receptor and Ser-473 phosphorylation of AKT [24]. This evidence concerns the gene GBA1 and ovarian cancer.